1. Biochemistry and Chemical Biology
  2. Neuroscience

Real-time in vivo imaging of extracellular ATP in the brain with a hybrid-type fluorescent sensor

  1. Nami Kitajima
  2. Kenji Takikawa
  3. Hiroshi Sekiya
  4. Kaname Satoh
  5. Daisuke Asanuma
  6. Hirokazu Sakamoto
  7. Shodai Takahashi
  8. Kenjiro Hanaoka
  9. Yasuteru Urano
  10. Shigeyuki Namiki
  11. Masamitsu Iino
  12. Kenzo Hirose  Is a corresponding author
  1. The University of Tokyo, Japan
  2. Nihon University School of Medicine, Japan
https://doi.org/10.7554/eLife.57544
Share this article
Cite this article
  1. Nami Kitajima
  2. Kenji Takikawa
  3. Hiroshi Sekiya
  4. Kaname Satoh
  5. Daisuke Asanuma
  6. Hirokazu Sakamoto
  7. Shodai Takahashi
  8. Kenjiro Hanaoka
  9. Yasuteru Urano
  10. Shigeyuki Namiki
  11. Masamitsu Iino
  12. Kenzo Hirose
(2020)
Real-time in vivo imaging of extracellular ATP in the brain with a hybrid-type fluorescent sensor
eLife 9:e57544.
https://doi.org/10.7554/eLife.57544
  2. Download BibTeX
  3. Download .RIS

Abstract

Adenosine 5' triphosphate (ATP) is a ubiquitous extracellular signaling messenger. Here, we describe a method for in-vivo imaging of extracellular ATP with high spatiotemporal resolution. We prepared a comprehensive set of cysteine-substitution mutants of ATP-binding protein, Bacillus FoF1-ATP synthase e subunit, labeled with small-molecule fluorophores at the introduced cysteine residue. Screening revealed that the Cy3-labeled glutamine-105 mutant (Q105C-Cy3; designated ATPOS) shows a large fluorescence change in the presence of ATP, with submicromolar affinity, pH-independence, and high selectivity for ATP over ATP metabolites and other nucleotides. To enable in-vivo validation, we introduced BoNT/C-Hc for binding to neuronal plasma membrane and Alexa Fluor 488 for ratiometric measurement. The resulting ATPOS complex binds to neurons in cerebral cortex of living mice, and clearly visualized a concentrically propagating wave of extracellular ATP release in response to electrical stimulation. ATPOS should be useful to probe the extracellular ATP dynamics of diverse biological processes in vivo.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Nami Kitajima

    Department of Pharmacology, The University of Tokyo, Bunkyo-ku, Japan
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9838-832X

  2. Kenji Takikawa

    Department of Pharmacology, The University of Tokyo, Bunkyo-ku, Japan
    Competing interests
    The authors declare that no competing interests exist.

  3. Hiroshi Sekiya

    Department of Physiology, The University of Tokyo, Bunkyo-ku, Japan
    Competing interests
    The authors declare that no competing interests exist.

  4. Kaname Satoh

    Department of Pharmacology, The University of Tokyo, Bunkyo-ku, Japan
    Competing interests
    The authors declare that no competing interests exist.

  5. Daisuke Asanuma

    Department of Pharmacology, The University of Tokyo, Bunkyo-ku, Japan
    Competing interests
    The authors declare that no competing interests exist.

  6. Hirokazu Sakamoto

    Department of Pharmacology, The University of Tokyo, Bunkyo-ku, Japan
    Competing interests
    The authors declare that no competing interests exist.

  7. Shodai Takahashi

    Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Japan
    Competing interests
    The authors declare that no competing interests exist.

  8. Kenjiro Hanaoka

    Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Japan
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0797-4038

  9. Yasuteru Urano

    Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Japan
    Competing interests
    The authors declare that no competing interests exist.

  10. Shigeyuki Namiki

    Department of Pharmacology, The University of Tokyo, Bunkyo-ku, Japan
    Competing interests
    The authors declare that no competing interests exist.

  11. Masamitsu Iino

    Cellular and Molecular Pharmacology, Nihon University School of Medicine, Tokyo, Japan
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6426-4206

  12. Kenzo Hirose

    Department of Pharmacology, The University of Tokyo, Bunkyo-ku, Japan
    For correspondence
    kenzoh@m.u-tokyo.ac.jp
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8944-6513

Funding

Ministry of Education, Culture, Sports, Science, and Technology (17H04029)

  • Kenzo Hirose

Ministry of Education, Culture, Sports, Science, and Technology (17K08584)

  • Shigeyuki Namiki

Japan Science and Technology Agency (JPMJPR17P1)

  • Daisuke Asanuma

Takeda Science Foundation

  • Nami Kitajima

Ministry of Education, Culture, Sports, Science, and Technology (19K22247)

  • Kenzo Hirose

Ministry of Education, Culture, Sports, Science, and Technology (25221304)

  • Masamitsu Iino

Ministry of Education, Culture, Sports, Science, and Technology (18K14915)

  • Hiroshi Sekiya

Ministry of Education, Culture, Sports, Science, and Technology (17H04764)

  • Daisuke Asanuma

Ministry of Education, Culture, Sports, Science, and Technology (18H04726)

  • Daisuke Asanuma

Ministry of Education, Culture, Sports, Science, and Technology (19K16251)

  • Hirokazu Sakamoto

Ministry of Education, Culture, Sports, Science, and Technology (18H04609)

  • Kenjiro Hanaoka

Ministry of Education, Culture, Sports, Science, and Technology (19H05414)

  • Kenjiro Hanaoka

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All procedures used in animal experiments were in accordance with the guidelines established by the Animal Welfare Committee of the University of Tokyo (Medicine-P10-010, Medicine-P15-017 and Medicine-P19-092).

Reviewing Editor

  1. Yamuna Krishnan, University of Chicago, United States

Publication history

  1. Received: April 3, 2020
  2. Accepted: July 9, 2020
  3. Accepted Manuscript published: July 10, 2020 (version 1)
  4. Version of Record published: August 3, 2020 (version 2)

Copyright

© 2020, Kitajima et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 8,786
    Page views
  • 1,035
    Downloads
  • 28
    Citations

Article citation count generated by polling the highest count across the following sources: Scopus, Crossref, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Nami Kitajima
  2. Kenji Takikawa
  3. Hiroshi Sekiya
  4. Kaname Satoh
  5. Daisuke Asanuma
  6. Hirokazu Sakamoto
  7. Shodai Takahashi
  8. Kenjiro Hanaoka
  9. Yasuteru Urano
  10. Shigeyuki Namiki
  11. Masamitsu Iino
  12. Kenzo Hirose
(2020)
Real-time in vivo imaging of extracellular ATP in the brain with a hybrid-type fluorescent sensor
eLife 9:e57544.
https://doi.org/10.7554/eLife.57544

Categories and tags

Research organism

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics

    Timeline of changes in spike conformational dynamics in emergent SARS-CoV-2 variants reveal progressive stabilization of trimer stalk with altered NTD dynamics

    Sean M Braet, Theresa SC Buckley ... Ganesh S Anand
    Research Article Updated

    SARS-CoV-2 emergent variants are characterized by increased viral fitness and each shows multiple mutations predominantly localized to the spike (S) protein. Here, amide hydrogen/deuterium exchange mass spectrometry has been applied to track changes in S dynamics from multiple SARS-CoV-2 variants. Our results highlight large differences across variants at two loci with impacts on S dynamics and stability. A significant enhancement in stabilization first occurred with the emergence of D614G S followed by smaller, progressive stabilization in subsequent variants. Stabilization preceded altered dynamics in the N-terminal domain, wherein Omicron BA.1 S showed the largest magnitude increases relative to other preceding variants. Changes in stabilization and dynamics resulting from S mutations detail the evolutionary trajectory of S in emerging variants. These carry major implications for SARS-CoV-2 viral fitness and offer new insights into variant-specific therapeutic development.

    1. Biochemistry and Chemical Biology

    Reserpine maintains photoreceptor survival in retinal ciliopathy by resolving proteostasis imbalance and ciliogenesis defects

    Holly Y Chen, Manju Swaroop ... Anand Swaroop
    Research Article

    Ciliopathies manifest from sensory abnormalities to syndromic disorders with multi-organ pathologies, with retinal degeneration a highly penetrant phenotype. Photoreceptor cell death is a major cause of incurable blindness in retinal ciliopathies. To identify drug candidates to maintain photoreceptor survival, we performed an unbiased, high-throughput screening of over 6,000 bioactive small molecules using retinal organoids differentiated from induced pluripotent stem cells (iPSC) of rd16 mouse, which is a model of Leber congenital amaurosis (LCA) type 10 caused by mutations in the cilia-centrosomal gene CEP290. We identified five non-toxic positive hits, including the lead molecule reserpine, which maintained photoreceptor development and survival in rd16 organoids. Reserpine also improved photoreceptors in retinal organoids derived from induced pluripotent stem cells of LCA10 patients and in rd16 mouse retina in vivo. Reserpine-treated patient organoids revealed modulation of signaling pathways related to cell survival/death, metabolism, and proteostasis. Further investigation uncovered dysregulation of autophagy associated with compromised primary cilium biogenesis in patient organoids and rd16 mouse retina. Reserpine partially restored the balance between autophagy and the ubiquitin-proteasome system at least in part by increasing the cargo adaptor p62, resulting in improved primary cilium assembly. Our study identifies effective drug candidates in preclinical studies of CEP290 retinal ciliopathies through cross-species drug discovery using iPSC-derived organoids, highlights the impact of proteostasis in the pathogenesis of ciliopathies, and provides new insights for treatments of retinal neurodegeneration.

    1. Biochemistry and Chemical Biology

    Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors

    Lisa Goebel, Tonia Kirschner ... Daniel Rauh
    Short Report

    Mutations within Ras proteins represent major drivers in human cancer. In this study, we report the structure-based design, synthesis, as well as biochemical and cellular evaluation of nucleotide-based covalent inhibitors for KRasG13C, an important oncogenic mutant of Ras that has not been successfully addressed in the past. Mass spectrometry experiments and kinetic studies reveal promising molecular properties of these covalent inhibitors, and X-ray crystallographic analysis has yielded the first reported crystal structures of KRasG13C covalently locked with these GDP analogues. Importantly, KRasG13C covalently modified with these inhibitors can no longer undergo SOS-catalysed nucleotide exchange. As a final proof-of-concept, we show that in contrast to KRasG13C, the covalently locked protein is unable to induce oncogenic signalling in cells, further highlighting the possibility of using nucleotide-based inhibitors with covalent warheads in KRasG13C-driven cancer.